Tg Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Tg Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Tg Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Tg Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $21M | 633k | 33.23 |
| 2025-12-31 | $18M | 606k | 29.81 |
| 2025-09-30 | $35M | 959k | 36.12 |
| 2025-06-30 | $56M | 1.5M | 35.99 |
| 2025-03-31 | $15M | 391k | 39.43 |
| 2024-12-31 | $8.9M | 297k | 30.10 |
| 2024-09-30 | $1.9M | 82k | 23.40 |
| 2024-06-30 | $1.6M | 88k | 17.80 |
| 2024-03-31 | $1.3M | 86k | 15.22 |
| 2023-12-31 | $1.4M | 81k | 17.09 |
| 2023-09-30 | $446k | 53k | 8.36 |
| 2023-06-30 | $7.4M | 298k | 24.84 |
| 2023-03-31 | $1.1M | 75k | 15.05 |
| 2022-12-31 | $1.1M | 93k | 11.83 |
| 2022-03-31 | $5.5M | 581k | 9.51 |
| 2021-12-31 | $11M | 581k | 19.00 |
| 2021-09-30 | $47M | 1.4M | 33.28 |
| 2021-06-30 | $73M | 1.9M | 38.79 |
| 2021-03-31 | $78M | 1.6M | 48.20 |
| 2020-12-31 | $73M | 1.4M | 52.02 |
| 2020-09-30 | $1.4M | 51k | 26.76 |
| 2018-09-30 | $220k | 39k | 5.60 |
| 2018-06-30 | $512k | 39k | 13.15 |
| 2018-03-31 | $564k | 40k | 14.19 |
| 2017-12-31 | $432k | 53k | 8.19 |
| 2017-06-30 | $148k | 15k | 10.04 |
| 2017-03-31 | $171k | 15k | 11.63 |
| 2016-12-31 | $68k | 15k | 4.63 |
| 2016-09-30 | $114k | 15k | 7.76 |